0RD1.L - Camurus AB (publ)
LSE - LSE Delayed price. Currency in SEK
85.18
-16.02 (-15.83%)
At close: 4:17PM BST
Stock chart is not supported by your current browser
| Previous close | 101.20 |
| Open | 83.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 83.30 - 85.18 |
| 52-week range | 83.30 - 85.18 |
| Volume | 13 |
| Avg. volume | N/A |
| Market cap | 3.977B |
| Beta (3Y monthly) | 0.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -6.99 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Does Camurus AB (publ) (STO:CAMX) Have A Particularly Volatile Share Price?
If you own shares in Camurus AB (publ) (STO:CAMX) then it's worth thinking about how it contributes to the volatility...
- PR Newswire
Buvidal® Weekly and Buvidal® Monthly (CAM2038) Approved in Australia as the First Long-acting Treatment of Opioid Dependence
LUND, Sweden , Nov. 28, 2018 /PRNewswire/ -- Camurus announced today that the Australian Therapeutic Goods Administration (TGA) has approved the company's lead products Buvidal® Weekly and Buvidal® Monthly ...
- PR Newswire
Camurus Receives EU Approval for Weekly and Monthly Buvidal® (CAM2038) for Opioid Dependence
- Buvidal® is the first long-acting medicine approved in the EU for the treatment of opioid dependence in adults and adolescents LUND, Sweden , Nov. 22, 2018 /PRNewswire/ -- Camurus announced today that ...
